[artículo] 
inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 563-568

Título :	Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder : A randomized, double blind, controlled study
Tipo de documento:	texto impreso
Autores:	Chien Ho Lin, Autor ; Shih Hsien Lin, Autor ; Fong Lin Jang, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 563-568
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Aripiprazol, Trastorno depresivo mayor, No refractario
Resumen:	Second-generation (atypical) antipsychotics have been accepted as an adjunctive medication in patients with treatment-resistant depression. This clinical trial evaluated the efficacy and safety of low-dose aripiprazole combined with regular-dose sertraline for acute major depressive episode in non-treatment-resistant depression outpatients.
Link:	./index.php?lvl=notice_display&id=29349

[artículo] Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder : A randomized, double blind, controlled study [texto impreso] / Chien Ho Lin, Autor ; Shih Hsien Lin, Autor ; Fong Lin Jang, Autor . - 2022 . - pp. 563-568.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 563-568

Palabras clave:	Aripiprazol, Trastorno depresivo mayor, No refractario
Resumen:	Second-generation (atypical) antipsychotics have been accepted as an adjunctive medication in patients with treatment-resistant depression. This clinical trial evaluated the efficacy and safety of low-dose aripiprazole combined with regular-dose sertraline for acute major depressive episode in non-treatment-resistant depression outpatients.
Link:	./index.php?lvl=notice_display&id=29349